comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - Εμβόλια - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. Η χρήση αυτού του εμβολίου θα πρέπει να γίνεται σύμφωνα με τις επίσημες συστάσεις.
rasilez
noden pharma dac - αλισκιρένη - Υπέρταση - Παράγοντες που δρουν στο σύστημα ρενίνης-αγγειοτενσίνης - Θεραπεία της ιδιοπαθούς υπέρτασης.
gencebok
gennisium pharma - Κιτρική καφεΐνη - Άπνοια - psychoanaleptics, - Θεραπεία της πρωτοπαθούς άπνοιας των πρόωρων νεογνών.
farcyclin 500mg/2ml amp ενεσιμο διαλυμα
angelini pharma hellas ΑΝΩΝΥΜΗ ΒΙΟΜΗΧΑΝΙΚΗ & ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΠΑΡΑΓΩΓΗΣ & ΕΜΠΟΡΙΑΣ ΦΑΡΜΑΚΩΝ Δ.Τ. angelini pharma hellas abee - amikacin sulfate - ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ - 500mg/2ml amp - 0039831555 - amikacin sulfate - 333.800000 mg - amikacin
piperacillin+tazobactam/generics pd.sol.inf (2+0,25)g/vial
generics pharma hellas ΕΠΕ Αγίου Δημητρίου 63, 17456 Αλιμος 210.9936410 - piperacillin sodium; tazobactam sodium - pd.sol.inf (ΚΟΝΙΣ ΓΙΑ ΔΙΑΛΥΜΑ ΠΡΟΣ ΕΓΧΥΣΗ) - (2+0,25)g/vial - piperacillin sodium 2,085g; tazobactam sodium 263,3mg - piperacillin and enzyme inhibitor
piperacillin+tazobactam/generics pd.sol.inf (4+0,5)g/vial
generics pharma hellas ΕΠΕ Αγίου Δημητρίου 63, 17456 Αλιμος 210.9936410 - piperacillin sodium; tazobactam sodium - pd.sol.inf (ΚΟΝΙΣ ΓΙΑ ΔΙΑΛΥΜΑ ΠΡΟΣ ΕΓΧΥΣΗ) - (4+0,5)g/vial - piperacillin sodium 4,17g; tazobactam sodium 536,6mg - piperacillin and enzyme inhibitor
lataneau ey.dro.sol 50mcg/1ml (0,005% w/v)
ΕΞΕΛΙΞΗ-ΕΜΠΟΡΙΑ ΙΑΤΡ.ΕΙΔΩΝ Α.Ε. Δ.Τ.ΕΞΕΛΙΞΗ Α.Ε./exelixis sa Λ. Μεσογείων 501,, 153 43 153 43, Αγ. Παρασκευή 210.6010910 - latanoprost - ey.dro.sol (ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ) - 50mcg/1ml (0,005% w/v) - latanoprost 0,05mg - latanoprost
bicofen f.c.tab 300mg/tab
ΦΑΡΜΕΞ Α.Ε. Λ. Κηφισού 132,, 121 31 121 31, Περιστέρι 210.5199200 - roxithromycin - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 300mg/tab - roxithromycin 300mg - roxithromycin
paclitol 6 mg/ml c/s.sol.in
ΦΑΡΜΑΝΕΛ ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. - paclitaxel - ΠΥΚΝΟ ΔΙΑΛΥΜΑ ΓΙΑ ΠΑΡΑΣΚΕΥΗ ΔΙΑΛΥΜΑΤΟΣ ΠΡΟΣ ΕΓΧΥΣΗ - 6 mg/ml - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
pentrexyl 250mg/cap caps
bristol myers squibb aebe - ampicillin trihydrate - ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ - 250mg/cap - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ